Fmr LLC Prelude Therapeutics Inc Transaction History

Fmr LLC

$1.52 Trillion
Q2 2024

A detailed history of Fmr LLC transactions in Prelude Therapeutics Inc stock. As of the latest transaction made, Fmr LLC holds 9,575 shares of PRLD stock, worth $23,363. This represents 0.0% of its overall portfolio holdings.

Number of Shares

9,575

Previous 11,550 17.1%

Holding current value

$23,363

Previous $54,000 33.33%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$3.32 - $5.63 $6,557 - $11,119	-1,975 Reduced 17.1%	9,575 $36,000
Q1 2024 May 13, 2024	SELL	$2.68 - $4.84 $678,407 - $1.23 Million	-253,137 Reduced 95.64%	11,550 $54,000
Q4 2023 Feb 13, 2024	SELL	$1.69 - $4.37 $8.22 Million - $21.3 Million	-4,866,746 Reduced 94.84%	264,687 $1.13 Million
Q3 2023 Nov 13, 2023	SELL	$2.74 - $4.79 $2.22 Million - $3.87 Million	-808,787 Reduced 13.62%	5,131,433 $15.9 Million
Q2 2023 Aug 11, 2023	BUY	$4.45 - $8.12 $6.2 Million - $11.3 Million	1,393,542 Added 30.65%	5,940,220 $26.7 Million
Q1 2023 May 11, 2023	SELL	$4.58 - $7.34 $196,546 - $314,988	-42,914 Reduced 0.94%	4,546,678 $25.9 Million
Q4 2022 Feb 13, 2023	SELL	$4.61 - $8.5 $225,682 - $416,117	-48,955 Reduced 1.06%	4,589,592 $27.7 Million
Q3 2022 Nov 10, 2022	BUY	$5.0 - $8.82 $1.68 Million - $2.96 Million	335,578 Added 7.8%	4,638,547 $30.7 Million
Q2 2022 Aug 12, 2022	SELL	$4.0 - $7.55 $4.28 Million - $8.07 Million	-1,068,938 Reduced 19.9%	4,302,969 $22.5 Million
Q1 2022 May 13, 2022	SELL	$6.9 - $13.22 $3.91 Million - $7.5 Million	-567,026 Reduced 9.55%	5,371,907 $37.1 Million
Q4 2021 Feb 14, 2022	SELL	$11.89 - $31.74 $13.3 Million - $35.4 Million	-1,116,733 Reduced 15.83%	5,938,933 $73.9 Million
Q3 2021 Nov 15, 2021	BUY	$25.78 - $38.65 $13 Million - $19.4 Million	503,167 Added 7.68%	7,055,666 $220 Million
Q2 2021 Aug 13, 2021	BUY	$28.63 - $44.3 $188 Million - $290 Million	6,552,499 New	6,552,499 $188 Million

Others Institutions Holding PRLD

# of Institutions

Shares Held

33.9M

Call Options Held

400

Put Options Held

100

View Full List

About Prelude Therapeutics Inc

Ticker PRLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,369,200
Market Cap $88.7M
Description
Prelude Therapeutics Incorporated, a clinical-stage precision oncology company, focuses on the discovery and development of novel precision cancer medicines to underserved patients. It is developing PRT543 that is in Phase 1 clinical trials in select solid tumors and myeloid malignancies; and PRT811, which is in Phase 1 clinical trials in solid ...

More about PRLD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.

Account